Summary
Probenecid was administered to 17 depressed, 19 manic and 15 control patients and further to 11 healthy volunteers. Before and after the administration the levels of 5-hydroxyindoleacetic acid (5-HIAA) were determined in cerebrospinal fluid (CSF). In six of the depressed, seven of the manic and seven of the patients from the group of controls and volunteers also homovanillic acid (HVA) was determined in CSF. After the application of probenecid there is a significant increase in 5-HIAA and HVA in the control patients and healthy volunteers but not in the depressed and manic patients. No increase in HVA occurred in the depressed patients but in the manic ones the HVA values were almost as high as in the group of controls and healthy volunteers. It is suggested that the lack of increase in 5-HIAA and HVA after probenecid indicates an inhibition of the synthesis of the acids and thus of the corresponding amines (5-hydroxytryptamine and dopamine) in the brain.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anden, N.-E., B.-E. Roos, and B. Werdinius: On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorimetric method. Life Sci. 2, 448–460 (1963).
Andersson, H., and B.-E. Roos: 5-Hydroxyindoleacetic acid in cerebrospinal fluid after administration of 5hydroxytryptophan. I. Acta pharmacol. 26, 293–297 (1968).
Ashcroft, G. W., and D. F. Sharman: 5-Hydroxyindoles in human cerebrospinal fluids. Nature 186, 1050–1051 (1960).
—T.B.B. Crawford, D. Eccleston, D. F. Sharman, E. J. Mac Dougall, J. B. Stanton, and J. K. Binns: 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet 1966 II, 1049–1052.
Bernheimer, H., W. Birkmayer, and O. Hornykiewrez: Verteilung des 5-Hydroxytryptamins (Serotonin) im Gehirn des Menschen und sein Verhalten by Patienten mit Parkinson-Syndrom. Klin. Wschr. 39, 1056–1059 (1961).
Bowers, U.B. Jr., and F. Gerbode: CSF 5-HIAA: Effects of probenecid and paraehlorophenylalanine. Life Sci. 7, 773–776 (1968).
Coppen, A., D.M. Shaw, and A. Malleson: Changes in 5-hydroxytryptophan metabolism in depression. Brit. J. Psychiat. 111, 105–107 (1965).
—B. Herzberg, and R. Maggs: Tryptophan in the treatment of depression. Lancet 1967 II, 1178–1180.
Dencker, S. J., U. Malm, B.-E. Rods, and B. Werdinius Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania. J. Neurochem. 13, 1545–1548 (1966).
Despopulos, A., and H. Weissbach: Renal metabolism of 5-hydroxyindoleacetic acid. Amer. J. Physiol. 189, 548–550 (1957).
Guldberg, H. C., G. W. Ashcroft, and T.B.B. Crawford: Concentrations of 5-hydroxyindoleylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid. Life Sci. 5, 1571–1575 (1966).
Johansson, B., and B.-E. Roos: Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's syndrome. Proc. 8th Intern. Congress Neurol. Vienna, 1965, Tom. IV/1, 141–144 (1965).
— —: 5-Hydroxyindoleacetic acid and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome. Life Sci. 6, 1449–1454 (1967).
Neff, N. H., T. N. Tozer, and B. B. Brodie: A specialized transport system to transfer 5-HIAA directly from brain to blood. Pharmacologist 6, 162 (1964).
Olsson, R., and B.-E. Roos: 5-Hydroxyindoleacetic acid and homovanillic acid levels in the cerebrospinal fluid after probenecid treatment in patients with Parkinson's syndrome. Nature 219, 502–503 (1968).
Persson, T., and B.E. Roos: 5-Hydroxytryptophan for depression. Lancet 1967 II, 987.
Roos, B.-E., N.-E. Anden, and B. Werdinius: Effect of drugs on the levels of indole and phenolic acids in the central nervous system. Int. J. Neuro-pharmacol. 3, 117–122 (1964).
Shaw, D.M., F. Camps, and E. Eccleton: 5-Hydroxytryptamine in the hindbrain of depressive suicides. Brit. J. Psychiat. 113, 1407–1411 (1967).
Werdinius, B.: Effect of probenecid on the level of homovanillic acid in the corpus striatum. J. Pharm. 18, 546–547 (1966).
— Elimination of 3,4-dihydroxyphenylaeetic acid from the blood. Acta pharmacol. 25, 9–17 (1967).
— Effect of probenecid on the levels of monoamine metabolites in the rat brain. Acta pharmacol. 25, 18–23 (1967).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roos, B.E., Sjöström, R. 5-hydroxyindoleacetic acid (and homovanillic acid) levels in the cerebrospinal fluid after probenecid application in patiens with manic-depressive psychosis. Pharmacol. Clin. 1, 153–155 (1969). https://doi.org/10.1007/BF00456937
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00456937